• Home
  • Entertainment News
  • Viral
  • BBNaija
  • Nigerian Music
  • Relationship
  • Quiz
  • Memes
  • Contact Us
  • Advertise
Thursday, October 1, 2026
YabaLeftOnline
  • Home
  • Entertainment News
  • Viral News
  • News
No Result
View All Result
  • Home
  • Entertainment News
  • Viral News
  • News
No Result
View All Result
YabaLeftOnline
No Result
View All Result
Home Entertainment News

The Pharmacist Who Bought The Wu-Tang Mystery Album For $2Million.

Michael Badejoko by Michael Badejoko
December 9, 2015
Reading Time: 1 min read
Share on FacebookShare on Twitter

Wu-Tang Buyer

The secret buyer of the mysterious Wu-Tang Clan’s “Once Upon a Time in Shaolin” album has been revealed as Martin Shkreli; a pharmaceutical tycoon.

ReadAlso

No Content Available

The pharmacist is well known for hiking up the price on cancer/AIDS medication from $13.50 to $750 per pill.

SEE ALSO: Wu-Tang Clan Sells Secret Album For Millions | To Be Released Only In 88 Years. (Photos)

The pharmacist who purchased the album for a smashing $2 million, says he hasn’t even listened to it yet and doesn’t plan to anytime soon.

Apart of the purchase was Shkreli agreeing to keep the album top secret for 88 years.

Tags: Martin ShkreliMartin Shkreli Buys Wu-Tang AlbumThe Pharmacist Who Bought The Wu-Tang Mystery Album For $2Million

Related Posts

No Content Available
Next Post

Are You Digging Annie Idibia's New Look?

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

  • About
  • Advertise
  • Write For Us
  • Contact Us
Call us: +234 903 171 3513

© 2022 YABALEFTONLINE MEDIA

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist

No Result
View All Result
  • Home
  • Entertainment News
  • Viral
  • BBNaija
  • Nigerian Music
  • Relationship
  • Quiz
  • Memes
  • Contact Us
  • Advertise

© 2022 YABALEFTONLINE MEDIA

This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.